https://www.zonebourse.com/cours/action/SAB-BIOTHERAPEUTICS-INC-128645017/actualite/HVIVO-plc-annonce-que-la-FDA-accorde-les-designations-Breakthrough-Therapy-et-Fast-Track-au-candida-43659563/?utm_source=telegram&utm_medium=social&utm_campaign=share